Add like
Add dislike
Add to saved papers

Construction and Characterization of a New Recombinant Vector to Remove Sulfate Repression of dsz Promoter Transcription in Biodesulfurization of Dibenzothiophene.

Biodesulfurization (BDS) is an environmentally friendly desulfurizing process with the potential of replacing or adding to the current expensive technologies for sulfur removal from fossil fuels. The BDS, however, still suffers from low biocatalyst activity. One reason is repression of dsz promoter transcription in presence of inorganic sulfate that impedes translation of Dsz enzymes required for desulfurization pathway. One approach to solve this problem is replacing the native promoter with a new promoter that is no longer repressed. In this study, dsz genes from desulfurizing strain Rhodococcus sp. FUM94 was cloned in an alkane responsive promoter, pCom8, and expressed in Escherichia coli BL21 (DE3) as a host. The recombinant was not susceptible to inorganic sulfate in the culture medium. Desulfurizing activity of recombinant strain versus wild type indicated that in a sulfate containing medium, BDS yield of recombinant increased from 16.0% ± 0.9 to 34.0% ± 1.9% when dibenzothiophene (DBT) concentration (dissolved in ethanol) increased from 25 to 100 ppm. Also, 2-hydroxy biphenyl (2-HBP) production rate improved 8.5-fold (from 0.302 ± 0.020 to 2.57 ± 0.14 mmol 2-HBP (kg DCW)-1 h-1 ) at the same DBT concentration range. This is while no 2-HBP production was detected in FUM94 biphasic reaction. In a sulfate-free medium, wild type strain demonstrated desulfurization activity, but decreasing with the increase of DBT concentration dissolved in n -tetradecane. Whereas, the recombinant strain demonstrated increasing desulfurizing activity in a sulfate-containing high DBT concentration environment. Overall, the result of this molecular manipulation can be considered as a step forward toward commercialization of BDS technology.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app